Pharmaceutical Business Intelligence

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Bimatoprost, and what substitute generic drugs are available?

Bimatoprost is a drug marketed by Sandoz Inc, Apotex Inc, Alcon Res Ltd, and Lupin Ltd. and is included in five NDAs.

The generic ingredient in BIMATOPROST is bimatoprost. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the bimatoprost profile page.

Summary for Tradename: BIMATOPROST

Suppliers / Packagers: see list3
Bulk Api Vendors: see list35
Clinical Trials: see list73
Patent Applications: see list1,655
Drug Prices:see details
DailyMed Link:BIMATOPROST at DailyMed

Pharmacology for Tradename: BIMATOPROST

Drug ClassProstaglandin Analog
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
SOLUTION/DROPS;TOPICAL202719-001Apr 19, 2016RXNoNo► Subscribe► Subscribe
Lupin Ltd
SOLUTION/DROPS;OPHTHALMIC203991-001Feb 20, 2015RXNoYes► Subscribe► Subscribe
Apotex Inc
SOLUTION/DROPS;OPHTHALMIC090449-001Jul 20, 2015RXNoNo► Subscribe► Subscribe
Alcon Res Ltd
SOLUTION/DROPS;OPHTHALMIC202565-001May 5, 2015RXNoNo► Subscribe► Subscribe
Apotex Inc
SOLUTION/DROPS;TOPICAL201894-001Dec 1, 2014RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.